SPARSENTAN RECEPTOR OCCUPANCY MODELING, CLINICAL ACTIONS, AND SAFETY
Back
E-Poster
https://storage.unitedwebnetwork.com/files/1099/10103cf45332c05f5665d74df7896cfa.pdf
Abstract Title
SPARSENTAN RECEPTOR OCCUPANCY MODELING, CLINICAL ACTIONS, AND SAFETY
First Name *
Bruce
Last Name *
Hendry
Co-author 1
Donald Kohan donald.kohan@hsc.utah.edu University of Utah Health Division of Nephrology, School of Medicine Salt Lake City
Co-author 2
Rob Geletka rob.geletka@travere.com Travere Therapeutics, Inc. Medical Affairs San Diego
Co-author 3
Celia Jenkinson celia.jenkinson@travere.com Travere Therapeutics, Inc. Translational Pharmacology San Diego
Co-author 4
Shang-Chiung Chen charles.chen@zymeworks.com Travere Therapeutics, Inc. Clinical Pharmacology San Diego
Co-author 5
Patricia W Bedard patricia.bedard@travere.com Travere Therapeutics, Inc. Nonclinical Development San Diego
Co-author 6
Co-author 7
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
E-Poster Format Requirements
PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but
must be saved and submitted as PDF file
.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos